Rifaximin Tablets BP 550mg are a pharmaceutical solid oral formulation requiring controlled manufacturing, quality systems, analytical testing, documentation and market-specific regulatory consideration.
For pharmaceutical companies seeking a Rifaximin Tablets BP 550mg manufacturer and exporter, selection should extend beyond production capability to R&D, quality assurance, quality control, regulatory documentation, packaging and international supply.
Vasudha Life Science Pvt. Ltd., based in Karnataka, India, lists Rifaximin Tablets 200mg, 400mg and 550mg in its R&D portfolio. Companies can enquire about specifications, manufacturing feasibility, packaging, documentation and destination-market requirements.
Who Manufactures Rifaximin Tablets BP 550mg?
Vasudha Life Science Pvt. Ltd. lists Rifaximin Tablets 550mg in its R&D portfolio and describes a WHO-GMP-certified pharmaceutical manufacturing facility in Karnataka, India. Commercial manufacturing, applicable specifications and country-specific requirements should be confirmed with the company.
Rifaximin Tablets BP 550mg — Product Overview
| Product | Rifaximin Tablets |
|---|---|
| Strength | 550mg |
| Dosage form | Tablet |
| Active pharmaceutical ingredient | Rifaximin |
| Pharmacopoeial standard | BP, where applicable |
| Manufacturing model | Contract / third-party manufacturing, subject to requirements |
| Manufacturing base | India |
| Target markets | India and international markets |
| Manufacturer | Vasudha Life Science Pvt. Ltd. |
Rifaximin is an antibacterial ingredient used in oral pharmaceutical formulations. Approved indications and labeling vary by jurisdiction and product registration. Claims for any destination market should follow the locally approved product information.
Rifaximin Tablets 550mg Manufacturer in India
Vasudha Life Science operates as a pharmaceutical contract manufacturing company with formulation-development, manufacturing, quality and regulatory-support capabilities. Its R&D portfolio lists Rifaximin Tablets 200mg, 400mg and 550mg. Every proposed manufacturing project should be assessed for intended market, product specification, formulation, batch size, packaging and regulatory requirements.
Rifaximin Tablets BP 550mg Manufacturer & Exporter
International pharmaceutical manufacturing requires both production and destination-market planning. A Rifaximin 550mg project may include:
- API and raw-material requirements
- Formulation specifications and process controls
- In-process, finished-product and stability testing
- Packaging, artwork and labeling
- Batch, quality, regulatory and export documentation
- Destination-country registration and import requirements
Vasudha describes its global activities as including contract manufacturing, customized manufacturing solutions and support for international pharmaceutical businesses.
Rifaximin Tablets 550mg — Target International Markets
The target commercial markets are India, Myanmar, Cambodia, Philippines, Afghanistan, Nigeria, Côte d’Ivoire, Chile and Guatemala. Listing a market does not confirm that a specific Rifaximin 550mg product is registered or approved there. Registration, importation, labeling, packaging and documentation must be assessed separately.
Rifaximin Tablets 550mg for India
Manufacturing and labeling should be evaluated against the relevant Indian requirements and approved product documentation.
Rifaximin Tablets 550mg for Myanmar
Confirm local product specifications, packaging, labeling, documentation and import requirements before supply.
Rifaximin Tablets 550mg for Cambodia
Confirm registration, packaging, labeling and documentation requirements before commercial supply.
Rifaximin Tablets 550mg for Philippines
Establish quality documentation, packaging, regulatory requirements and product configuration with the local pharmaceutical partner.
Rifaximin Tablets 550mg for Afghanistan
The manufacturer and importer should establish registration, importation, packaging and documentation requirements before commercial manufacturing.
Rifaximin Tablets 550mg for Nigeria
Confirm applicable Nigerian registration, quality documentation and import requirements before commercial supply.
Rifaximin Tablets 550mg for Côte d’Ivoire
Evaluate local registration, packaging, labeling and import requirements with relevant stakeholders.
Rifaximin Tablets 550mg for Chile
Confirm product registration, packaging, labeling and supporting documentation under Chilean requirements.
Rifaximin Tablets 550mg for Guatemala
Establish registration, labeling, packaging and import documentation before commercial supply.
What Does BP Mean for Rifaximin Tablets 550mg?
BP means British Pharmacopoeia, which provides official standards for pharmaceutical substances and medicinal products. Applicable monographs, ingredient and general tablet requirements should be verified for the date of manufacture. BP 2026 became legally effective on 1 January 2026; standards are updated periodically.
Quality Control for Rifaximin Tablets 550mg
Testing is determined by the approved product specification and applicable pharmacopoeial and regulatory requirements. Depending on the product, it may cover:
- Appearance and identification
- Assay and uniformity of dosage units
- Dissolution and related substances
- Weight-related parameters
- Stability-related testing
- Microbiological and other product-specific analytical requirements, where applicable
Acceptance criteria must come from the applicable product specification and regulatory documentation. Vasudha describes QA oversight and QC capabilities supported by analytical instruments and skilled personnel. Learn about its quality control and quality assurance functions.
Rifaximin Tablets 550mg Manufacturing Process
The precise procedure depends on the approved formulation. A typical workflow can include:
- Raw-material procurement and supplier evaluation
- Incoming material testing and release
- Accurate dispensing against batch documentation
- Processing, granulation where applicable, and blending
- Tablet compression under controlled parameters
- Coating where required by the formulation
- In-process controls and finished-product testing
- Packaging appropriate to the product and destination market
- Quality review and release
Manufacturing processes and acceptance criteria must follow the approved documents for the specific product.
Why Choose a Rifaximin Tablets 550mg Manufacturer Carefully?
Pharmaceutical businesses should evaluate the full technical and quality system, not price alone.
Manufacturing Infrastructure
- Tablet production equipment
- Controlled environments
- Production planning
- Process controls and records
Quality Systems
- Quality Assurance and Quality Control
- Raw-material and in-process testing
- Finished-product and stability support
- Batch documentation
R&D Capabilities
- Formulation development
- Optimization and process development
- Scale-up and technical support
Regulatory Capabilities
- Regulatory affairs and documentation
- Market-specific requirements
- Packaging and labeling support
- Export documentation
Why Partner With Vasudha Life Science?
Established in 2014, Vasudha Life Science operates as a pharmaceutical contract manufacturing company in Karnataka, India. It describes a WHO-GMP-certified facility, R&D support, QA/QC oversight, regulatory affairs services and international contract manufacturing activities. Its documented R&D portfolio includes Rifaximin 550mg as well as 200mg and 400mg strengths. Commercial product-specific capability should be reconfirmed before contracting.
Explore Vasudha Life Science’s company profile, pharmaceutical R&D, manufacturing services, regulatory affairs and international manufacturing activities.
Rifaximin Tablets 550mg Third-Party Manufacturing
Third-party manufacturing may allow pharmaceutical companies to focus on marketing, sales, distribution, regulatory strategy and customer management while eligible production is outsourced. A project may progress through product-requirement discussion, technical evaluation, specification, batch-size planning, packaging, quality requirements, regulatory documentation, commercial evaluation, manufacturing and logistics. Arrangements depend on destination market, product feasibility and contractual terms.
Rifaximin Tablets 550mg Export From India
International buyers should agree on the destination country, product registration, strength and specification, applicable pharmacopoeial standards, stability, labeling, packaging, analytical and regulatory documents, batch quantities, forecasts and shipping requirements before finalizing the manufacturing project.
What Should Buyers Ask a Rifaximin 550mg Manufacturer?
Manufacturing
- Does the manufacturer support the required tablet formulation?
- What batch sizes, equipment and lead times are available?
Quality
- What QA/QC systems and analytical testing are available?
- How are incoming materials controlled and batches documented?
Regulatory
- Can market-specific documentation be supported?
- Which pharmacopoeial standards, packaging and labeling requirements apply?
Commercial
- What minimum-order quantities and packaging options are possible?
- What lead times and export documents are available?
Who Can Enquire About Rifaximin Tablets BP 550mg?
Potential B2B customers include pharmaceutical and generic-medicine companies, marketing authorization holders, importers, distributors, exporters, international healthcare businesses and companies seeking contract or third-party manufacturing. Feasibility depends on product specification, market, regulatory pathway and commercial requirements.
Frequently Asked Questions
Who manufactures Rifaximin Tablets BP 550mg?
Vasudha Life Science lists Rifaximin Tablets 550mg in its R&D portfolio and operates a pharmaceutical manufacturing business in Karnataka, India. Specific commercial feasibility must be confirmed.
Does Vasudha Life Science manufacture Rifaximin Tablets 550mg?
Rifaximin Tablets 550mg are included in Vasudha’s R&D portfolio. Contact the company to confirm current commercial manufacturing feasibility, specification and regulatory requirements.
What is Rifaximin Tablets 550mg?
An oral tablet formulation containing 550mg of rifaximin. Approved indications, labeling and dosage depend on the registered product and market.
What does BP mean in Rifaximin Tablets BP 550mg?
BP means British Pharmacopoeia; applicable standards must be confirmed for the relevant manufacturing date.
Can Rifaximin Tablets 550mg be exported from India?
Export manufacturing may be evaluated subject to the destination market’s registration, labeling, packaging, documentation and import requirements.
Which countries are targeted for Rifaximin Tablets 550mg?
India, Myanmar, Cambodia, Philippines, Afghanistan, Nigeria, Côte d’Ivoire, Chile and Guatemala are target commercial markets, not claims of existing product approvals.
Can the same specification be used in every country?
Not necessarily. Registration, labeling, packaging and documentation requirements may vary by country.
Can Rifaximin 550mg be third-party manufactured?
Vasudha offers contract manufacturing services and lists 550mg rifaximin in its R&D portfolio; specific arrangements require confirmation.
What should I check before selecting a manufacturer?
Evaluate GMP status, infrastructure, R&D, QA/QC, analytical testing, documentation, regulatory and packaging support, planning and market experience.
Conclusion
Selecting a Rifaximin Tablets BP 550mg manufacturer and exporter requires evaluating manufacturing infrastructure, quality systems, technical expertise, regulatory support and destination-market requirements. Vasudha Life Science lists Rifaximin Tablets 550mg in its R&D portfolio. Buyers targeting India and international markets should separately verify specifications, registration, packaging and documentation.
Contact Vasudha Life Science Pvt. Ltd. to discuss manufacturing feasibility, third-party manufacturing and international supply requirements.
Registered Office / Factory: 256 – 2A & 2B, Neelavara Village, Kunjal, Brahmavara – 576213, Udupi District, Karnataka, India.
Phone: +91 98333 40428
Email: info@vasudhalifescience.com
Regulatory note: Information is intended for pharmaceutical business discussions only. Product approval, labeling, specifications and supply eligibility depend on applicable jurisdictional requirements. This article is not prescribing advice.